COMPLETE FACIAL REJUVENATION
Smooth, beautiful skin is something all of us aspire to have, but unfortunately aging, hormones and genes sometimes make it a lofty goal and one that some people may seek out laser treatments to achieve. Because not everyone can take a week off to recover from something like ablative fractional skin resurfacing laser treatments (one of the main treatment choices when it comes to treating severe acne scarring or deep wrinkles, up until now), new non-ablative skin resurfacing treatments have been created.
The eTWO device, developed by Syneron-Candela, offers a non-ablative way to rejuvenate skin to treat wrinkles or scars while simultaneously tightening the skin. In combining two of their other FDA-approved Sublime™ (also known as ReFirme) and Sublative™ (also known as eMatrix) applications, a “comprehensive facial rejuvenation” experience is created with minimal downtime: two to three hours with the max of a day or two. This major advantage makes it the “go-to machine” for people in the real world who can’t have a lot of downtime.
Sublime uses a combination of infrared light and bi-polar radio frequency to provide deep dermal heating to improve wrinkles and facial contour. The Sublative, also known as the eMatrix, delivers bi-polar frequency energy to initiate a strong wound-healing response that smoothes the skin but does not damage it as other traditional laser treatments can. One of the other main advantages to using this device is the ability to customize the delivery. Think of an ice cream cone, upside down, that’s how it’s delivered to the skin. It can be customize versus a laser beam which is straight down. Other beneficial aspects to this treatment include the fact that it’s an excellent option for patients of color, its quick – typically 20 to 40 minutes depending on the area treated and it requires a short treatment protocol – three treatments (four for acne scars) spaced a month apart.
For those of patients who don’t have the time to wait and recover, eTWO is Mika's “go-to” choice treatment.